Beranda › Obesitas › Rhode Island
Uji klinis Obesitas di Rhode Island
19 studi untuk Obesitas mencari peserta di lokasi di Rhode Island.
Kota di Rhode Island
Teks studi resmi (Bahasa Inggris)
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- University Gastroenterology, Providence
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- University Gastroenterology, Providence
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937086AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07339423Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Providence, East Greenwich
Menerima pesertaFase 3
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, East Greenwich
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, East Greenwich
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07284979Cognitive Strategies for Weight Loss
- Weight Control & Diabetes Research Center, Providence
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT05799846Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- Women and Infants Hospital of Rhode Island, Providence
Menerima peserta
Usia 18 hingga 45 · Wanita · Diperbarui 24 Jun 2026 · NCT05124808Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
- Brown University, Providence
Menerima peserta
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT06948058Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
- Rhode Island Hospital, Providence
Menerima pesertaSukarelawan sehat diterima
Usia 7 hingga 12 · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT06861868Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
- The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University, Providence
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 4 Feb 2026 · NCT07228130Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
- Weight Control and Diabetes Research Center, Providence
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07363616Weight Management Intervention in College: A Pilot
- The Miriam Hospital, Providence
Menerima peserta
Usia 18 hingga 29 · Semua jenis kelamin · Diperbarui 1 Okt 2025 · NCT06994923Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
- The Miriam Hospital's Weight Control and Diabetes Research Center, Providence
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mar 2025 · NCT06875622Optimizing an Online Behavioral Weight Loss Intervention and Novel Culturally Tailored Components for Sexual Minority Women
- Weight Control and Diabetes Research Center, Providence
Menerima peserta
Usia 18 hingga 70 · Wanita · Diperbarui 27 Des 2024 · NCT05775497Control Systems Engineering for Weight Loss Maintenance
- Miriam Hospital Weight Control and Diabetes Resarch Center, Providence
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Apr 2024 · NCT06244888Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.